Redcare Pharmacy NV (SHPPF)
USD 135.79
(0.0%)
USD 135.79
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 135.78 Million EUR | 36.18% |
| 2022 | 99.7 Million EUR | 3.19% |
| 2021 | 96.62 Million EUR | 18.94% |
| 2020 | 81.24 Million EUR | 43.31% |
| 2019 | 56.68 Million EUR | 30.77% |
| 2018 | 43.34 Million EUR | 8.4% |
| 2017 | 39.98 Million EUR | 55.82% |
| 2016 | 25.66 Million EUR | 59.75% |
| 2015 | 16.06 Million EUR | 58.7% |
| 2014 | 10.12 Million EUR | 21.28% |
| 2013 | 8.34 Million EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 133.7 Million EUR | -0.73% |
| 2024 Q1 | 134.69 Million EUR | -0.81% |
| 2023 Q2 | 119.23 Million EUR | 21.89% |
| 2023 Q3 | 128.38 Million EUR | 7.67% |
| 2023 FY | 135.78 Million EUR | 36.18% |
| 2023 Q1 | 97.82 Million EUR | -1.89% |
| 2023 Q4 | 135.78 Million EUR | 5.77% |
| 2022 Q1 | 75.23 Million EUR | -22.14% |
| 2022 Q3 | 78.54 Million EUR | 4.81% |
| 2022 FY | 99.7 Million EUR | 3.19% |
| 2022 Q2 | 74.93 Million EUR | -0.4% |
| 2022 Q4 | 99.7 Million EUR | 26.95% |
| 2021 Q3 | 74.85 Million EUR | -6.26% |
| 2021 Q1 | 82.82 Million EUR | 1.94% |
| 2021 FY | 96.62 Million EUR | 18.94% |
| 2021 Q4 | 96.62 Million EUR | 29.08% |
| 2021 Q2 | 79.85 Million EUR | -3.58% |
| 2020 Q2 | 76.95 Million EUR | 37.79% |
| 2020 Q1 | 55.84 Million EUR | -1.48% |
| 2020 FY | 81.24 Million EUR | 43.31% |
| 2020 Q4 | 81.24 Million EUR | 11.32% |
| 2020 Q3 | 72.98 Million EUR | -5.16% |
| 2019 Q2 | 42.77 Million EUR | -12.29% |
| 2019 FY | 56.68 Million EUR | 30.77% |
| 2019 Q4 | 56.68 Million EUR | 28.06% |
| 2019 Q3 | 44.26 Million EUR | 3.5% |
| 2019 Q1 | 48.76 Million EUR | 12.49% |
| 2018 Q4 | 43.34 Million EUR | 27.62% |
| 2018 FY | 43.34 Million EUR | 8.4% |
| 2018 Q1 | 34.36 Million EUR | -14.07% |
| 2018 Q2 | 30.87 Million EUR | -10.16% |
| 2018 Q3 | 33.96 Million EUR | 10.03% |
| 2017 Q3 | 25.03 Million EUR | 29.63% |
| 2017 FY | 39.98 Million EUR | 55.82% |
| 2017 Q4 | 39.98 Million EUR | 59.74% |
| 2017 Q1 | 22.7 Million EUR | -11.54% |
| 2017 Q2 | 19.31 Million EUR | -14.93% |
| 2016 Q1 | - EUR | -100.0% |
| 2016 Q2 | 14.66 Million EUR | 0.0% |
| 2016 Q4 | 25.66 Million EUR | 36.03% |
| 2016 Q3 | 18.86 Million EUR | 28.69% |
| 2016 FY | 25.66 Million EUR | 59.75% |
| 2015 Q4 | 16.06 Million EUR | 0.0% |
| 2015 FY | 16.06 Million EUR | 58.7% |
| 2015 Q1 | - EUR | 0.0% |
| 2014 FY | 10.12 Million EUR | 21.28% |
| 2013 FY | 8.34 Million EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | - USD | -Infinity% |
| Allstar Health Brands, Inc. | - USD | -Infinity% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 129.52 Million USD | -4.837% |
| Café Serendipity Holdings, Inc. | - USD | -Infinity% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | 0.64 USD | -21216562400.0% |
| HealthWarehouse.com, Inc. | 509.11 Thousand USD | -26570.936% |
| LIGAND PHARMACEUTICAL INC | 23.96 Million USD | -466.507% |
| MedGen, Inc. | - USD | -Infinity% |
| Omni Health, Inc. | 380.1 Thousand USD | -35622.911% |
| Oxford Investments Holdings Inc. | 124.35 Thousand USD | -109094.866% |
| Pineapple, Inc. | 4710.00 USD | -2882829.936% |
| ScripsAmerica, Inc. | 735.76 Thousand USD | -18355.128% |